By How Much Is Colgate-Palmolive’s Revenue & EBITDA Expected to Grow In The Next 5 Years?
- Revenue: 15% growth driven by expansion and market share gains in premium Oral Care
- EBITDA: ~20% growth primarily driven by revenue growth and margin accretion in Oral Care
Have more questions on Colgate-Palmolive (NYSE:CL)? See the links below:
- What is Colgate-Palmolive’s Current Revenue and Gross Profit Breakdown?
- What Is Colgate-Palmolive’s Fundamental Value Based On Expected 2016 Results?
- How Has Colgate-Palmolive’s Revenue and Gross Profit Composition Changed Over The Last Five Years?
- By How Much Has Colgate-Palmolive’s Revenue & Gross Profit Changed In The Last 5 Years?
- How Is Colgate-Palmolive’s Revenue and Gross Profit Composition Expected To Change In The Future?
- How Much Are Colgate-Palmolive’s Business Divisions Worth Individually?
Relevant Articles
- Should You Pick Colgate-Palmolive Stock Over Monster Beverage After The Latter’s 2x Gains This Year?
- Should You Pick Colgate-Palmolive Stock After A Q3 Beat And 4% Gains This Month?
- Is Colgate-Palmolive Stock A Better Pick Over Marriott?
- Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
- Should You Buy Colgate-Palmolive Stock At $80?
- Should You Buy This Households & Personal Products Company Over Colgate-Palmolive Stock?
Notes:
1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Colgate-Palmolive
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)